Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Hoge Elizabeth — Cartesian Therapeutics, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Hoge Elizabeth

Hoge Elizabeth

10% owner at Cartesian Therapeutics, Inc. · on record since Apr 6, 2026

Insider trading activity of Hoge Elizabeth

Transactions on record: 2; since Apr 6, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Apr 6, 2026

Figures computed from official regulatory filings — methodology.

Companies where Hoge Elizabeth has traded

Cartesian Therapeutics, Inc.2 tx · Apr 6, 2026

Track record of Hoge Elizabeth

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Hoge Elizabeth

Co-insiders of Hoge Elizabeth

Abraham DavidCartesian Therapeutics, Inc.
AFEYAN NOUBARCartesian Therapeutics, Inc.
ANDO GORANCartesian Therapeutics, Inc.
BARABE TIMOTHY CCartesian Therapeutics, Inc.
Bot Adrian IonCartesian Therapeutics, Inc.
Brunn CarstenCartesian Therapeutics, Inc.
CAUTREELS WERNERCartesian Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

COX CARRIE SMITHCartesian Therapeutics, Inc.

Dahms Bradford D.Cartesian Therapeutics, Inc.

Davis BlaineCartesian Therapeutics, Inc.

DeSilva Nishan MCartesian Therapeutics, Inc.

Donohue Ann K.Cartesian Therapeutics, Inc.

English EmilyCartesian Therapeutics, Inc.

Farokhzad OmidCartesian Therapeutics, Inc.

Flagship Ventures 2007 General Partner LLCCartesian Therapeutics, Inc.

Flagship Ventures Fund 2007, L.P.Cartesian Therapeutics, Inc.

GORDON CARL LCartesian Therapeutics, Inc.

HUTT PETER BARTONCartesian Therapeutics, Inc.

ISALY SAMUEL DCartesian Therapeutics, Inc.

Jewell Christopher MCartesian Therapeutics, Inc.

Johnston Lloyd P.Cartesian Therapeutics, Inc.

Kalayoglu MuratCartesian Therapeutics, Inc.

KANIA EDWIN M JRCartesian Therapeutics, Inc.

Keller PeterCartesian Therapeutics, Inc.

Kishimoto Takashi KeiCartesian Therapeutics, Inc.

Kogan Elona Esq.Cartesian Therapeutics, Inc.

Kurtoglu MetinCartesian Therapeutics, Inc.

LANGER ROBERTCartesian Therapeutics, Inc.

Leaman John HaroldCartesian Therapeutics, Inc.

Leukon Investments, LPCartesian Therapeutics, Inc.

Malik KemalCartesian Therapeutics, Inc.

Miljkovic MilosCartesian Therapeutics, Inc.

Myers Scott DunsethCartesian Therapeutics, Inc.

Nanodimension Limited PartnershipCartesian Therapeutics, Inc.

Nanodimension Management LtdCartesian Therapeutics, Inc.

Nashat AmirCartesian Therapeutics, Inc.

ORBIMED ADVISORS LLCCartesian Therapeutics, Inc.

OrbiMed Capital GP III LLCCartesian Therapeutics, Inc.

Osage Partners, LLCCartesian Therapeutics, Inc.

Osage University GP II, L.P.Cartesian Therapeutics, Inc.

Osage University Partners II, L.P.Cartesian Therapeutics, Inc.

Polaris Venture Management Co. V, L.L.C.Cartesian Therapeutics, Inc.

Polaris Venture Partners Entrepreneurs' Fund V, L.P.Cartesian Therapeutics, Inc.

Polaris Venture Partners Founders' Fund V, L.P.Cartesian Therapeutics, Inc.

Polaris Venture Partners Special Founders' Fund V, L.P.Cartesian Therapeutics, Inc.

Polaris Venture Partners V, L.P.Cartesian Therapeutics, Inc.

RUSNANOCartesian Therapeutics, Inc.

Sallin AymericCartesian Therapeutics, Inc.

Sands EarlCartesian Therapeutics, Inc.

Schecter Alison D.Cartesian Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Cartesian Therapeutics, Inc.	Apr 6, 2026	Exercise	758,001	—	—	SEC
Cartesian Therapeutics, Inc.	Apr 6, 2026	ExerciseD	-22,740.03	—	—	SEC